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Background: Optimal fluid resuscitation strategy following combined traumatic brain injury (TBI) and hemorrhagic
shock (HS) remain controversial and the effect of resuscitation infusion speed on outcome is not well known. We
have previously reported that bolus infusion of fresh frozen plasma (FFP) protects the brain compared with bolus
infusion of 0.9% normal saline (NS). We now hypothesize reducing resuscitation infusion speed through a stepwise
infusion speed increment protocol using either FFP or NS would provide neuroprotection compared with a high
speed resuscitation protocol.
Methods: 23 Yorkshire swine underwent a protocol of computer controlled TBI and 40% hemorrhage. Animals
were left in shock (mean arterial pressure of 35 mmHg) for two hours prior to resuscitation with bolus FFP (n = 5,
50 ml/min) or stepwise infusion speed increment FFP (n = 6), bolus NS (n = 5, 165 ml/min) or stepwise infusion
speed increment NS (n = 7). Hemodynamic variables over a 6-hour observation phase were recorded. Following
euthanasia, brains were harvested and lesion size as well as brain swelling was measured.
Results: Bolus FFP resuscitation resulted in greater brain swelling (22.36 ± 1.03% vs. 15.58 ± 2.52%, p = 0.04),
but similar lesion size compared with stepwise resuscitation. This was associated with a lower cardiac output
(CO: 4.81 ± 1.50 l/min vs. 5.45 ± 1.14 l/min, p = 0.03). In the NS groups, bolus infusion resulted in both increased
brain swelling (37.24 ± 1.63% vs. 26.74 ± 1.33%, p = 0.05) as well as lesion size (3285.44 ± 130.81 mm3 vs.
2509.41 ± 297.44 mm3, p = 0.04). This was also associated with decreased cardiac output (NS: 4.37 ± 0.12 l/min
vs. 6.35 ± 0.10 l/min, p < 0.01).
Conclusions: In this clinically relevant model of combined TBI and HS, stepwise resuscitation protected the brain
compared with bolus resuscitation.
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Optimal fluid resuscitation strategies in patients with
hemorrhagic shock (HS) remain controversial, although
both crystalloids (1) and fresh frozen plasma (FFP) remain
key components of both pre and in-hospital resuscitation
strategies. Maintaining end-organ oxygenation by ensur-
ing adequate tissue perfusion pressures as well as reducing
edema formation by minimizing fluid extravasation is key
to the resuscitation success, regardless of fluid choice.
While the choice of resuscitation fluid has been the
subject of intense investigation [1,2], little is known of
the effect resuscitation speed. The Advanced Trauma* Correspondence: alamh@med.umich.edu
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unless otherwise stated.Life Support (ATLS) guidelines place emphasis on early
restoration of adequate tissue perfusion by rapid infusion
of crystalloids [3], thus theoretically minimizing the time
to adequate end organ oxygenation. In contrast, several
studies have indicated that rapid bolus infusion of crys-
talloids and artificial colloids may be associated with
lower post resuscitation systemic blood pressures and
higher mortality compared with slow or stepwise infusion
in general trauma [4-6]. If higher infusion speeds are
indeed associated with higher levels of fluid extravasation,
this may be particularly detrimental if HS is combined
with traumatic brain injury (TBI), owing to the confined
nature of the brain in the cranial cavity, the susceptibility
to hypoxia and the well established detrimental effects of
the associated intracranial pressure (ICP) changes [7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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our group has previously demonstrated that early bolus
resuscitation with FFP attenuates both lesion size and
fluid extravasation into the brain compared to bolus
resuscitation with 0.9% normal saline (NS). Using the
same model, we now hypothesize that stepwise infusion
speed increment resuscitation with FFP or NS will be
superior to bolus in reducing brain lesion size and
edema formation.
Method
All the research was conducted in compliance with the
Animal Welfare Act and other Federal statutes and reg-
ulations relating to animals and experiments involving
animals. The study adhered to the principles stated in
the Guide for the Care and Use of Laboratory Animals,
Institute for Laboratory Animal Research (1996) and was
approved by the appropriate Institutional Animal Care
and Use Committees. All the procedures were performed
under the supervision of a veterinarian.
A total 23 Female Yorkshire swine (40–50 kg; Tufts
Veterinary School, Grafton, MA) were used and allowed
three days for acclimatization prior to surgery. Of these,
20 animals were primarily used for and included in
other studies [8,9] with an identical protocol while the
remaining three animals were included for the purpose
of the present study. The aims of these other studies
were to compare the effects of different resuscitation
fluids on brain injury. The present study thus presents
secondary use of animal experiments previously published
as well as novel data from animals not previously
published.
Food was withheld the night before surgery, but access
to water was allowed. Preanesthesia was administered
with an intramuscular injection of Tiletamine/Zolazepam
(Telazol, 50 mg/ml), 8 mg/kg (Fort Dodge Animal Health,
Fort Dodge IA) and atropine sulfate 1.5 mg. Animals
were weighed and anesthesia was subsequently induced
with inhalation of 4% inspired fraction isoflurane in
100% oxygen. Animals were intubated with a 7.0 mm
cuffed endotracheal tube and put on ventilator support
(Narkomed-M, North American Dr\ager, Telford PA) with
a tidal volume of 10 ml/kg, peak pressure of 20 cm H20
and a respiratory rate of 10 breaths per minute. No
supplemental oxygen was administered following intub-
ation. Tidal volumes and respiratory rate was adjusted to
maintain a target end tidal PCO2 of 40 mmHg. Isoflurane
was adjusted to 1%-3% inspired fraction for maintenance
of anesthesia.
Instrumentation and monitoring
After induction of anesthesia, a cutdown technique was
used to access the right and left femoral arteries for
invasive blood pressure monitoring (Eagle 4000 patientmonitor, GE Marquette Piscataway NJ) and blood draw
respectively. The left femoral vein was cannulated for
fluid administration, whereas the right external jugular
vein was used for the insertion of a pulmonary artery (PA)
catheter. The PA catheter was used for measurements of
cardiac output, pulmonary and central venous pressures
as well as mixed venous oxygenation. A distal midline
laparotomy was performed for the insertion of a cystost-
omy tube. Hemodynamic parameters (V9004 SurgiVet,
Waukesha, WI), including cardiac output (Vigilance II
Monitor, Edwards Lifesciences, Irvine CA), were recorded
in five-minute intervals. The animal’s head was fixed in a
custom made stereotactic frame with a mouthpiece affixed
to the zygoma to prevent movement.
A 20 mm burr hole was made on the right side of the
skull, next to the coronal and sagittal sutures over the
frontal lobe to expose the dura. Bone was carefully re-
moved so as not to disturb the dura and the underlying
brain tissue. A catheter for intracranial pressure moni-
toring and monitoring of cerebral oxygenation (Integra
Lifesciences, Plainsboro, NJ) was inserted through a bolt
placed in a 2-mm burr hole on the left side of the skull,
10 mm lateral and 10 mm anterior to the bregma.
A computer-controlled cortical impact device was
used for these experiments. Briefly, a 15 mm cylindrical
impactor tip was mounted on an electronic motor, and
the dynamics were precisely controlled to deliver 4 m/s
velocity, 100 ms dwell time and 12 mm depth penetration.
After impact, the burr hole was sealed with bone wax to
prevent leakage of cerebrospinal fluid, and to eliminate
any artifact in ICP monitoring.
Hemorrhage and resuscitation protocol
Model outline is provided in Figure 1. Total blood volume
was estimated, and 40% of it was withdrawn through the
femoral arterial catheter using a Masterflex pump, Model
L/S Computerized Drive with a MF easy load II Pump-
head, Model 77201–60 (Cole-Palmer, Vernon Hills, IL).
Bleeding was started concurrent with TBI at a rate of
3.15% total blood volume/min and was captured in a
Terumo blood collection bag (CPDA and AS-5). Isoflur-
ane was decreased with the onset of hypotension. If MAP
dropped < 30 mmHg, hemorrhage was briefly held and a
small volume of saline was infused through the femoral
venous line. Once the MAP reached 35 mmHg, saline
infusion was stopped and hemorrhage was restarted.
Using this protocol, MAP was maintained between
30 mmHg and 35 mm Hg until 40% of the estimated
blood volume was withdrawn in a controlled fashion.
Following hemorrhage, animals were left in shock for
120 minutes and MAP was maintained between 30–
35 mmHg by titrating the dose of inhaled isoflurane. After
the 2 hours of shock, animals were resuscitated as follows:
Prior to the experiment, animals had been randomly
Figure 1 Model overview. Groups 1 and 4 were resuscitated with fixed infusion speeds as seen, whereas groups 2 and 3 were resuscitated with
stepwise speed increments. Speeds were increased once the given fluid volumes depicted in the group boxes had been infused.
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bolus infusion with FFP 1*shed blood volume (n = 5) at
50 ml/min, 2) Stepwise infusion of FFP 1*shed blood
with infusion speeds starting at 2 ml/min and gradually
increasing to 50 ml/min (n = 6), 3) stepwise infusion of
NS*3 shed blood volume with infusion speeds staring
at 6 ml/min and gradually increasing to 165 ml/min
(n = 6) and 4) bolus infusion of NS *3 shed blood volume
at 165 ml/min (n = 5). Bolus resuscitation protocols were
based on previous experiments [9]. The stepwise resusci-
tation protocols were the result of several pilot experi-
ments suggesting an optimal hemodynamic response
while minimizing resuscitation time and the extent of the
brain injury. Fluids were infused into the femoral vein
using a Masterflex pump. Animals were monitored for
six hours post resuscitation and were kept warm (Bair
Hugger Model 505; Arizant Healthcare Inc., Eden Praire,
MN). Electrolytes were corrected as needed. Following the
six-hour observation period, animals were euthanized by
intravenous injection of sodium pentobarbital 100 mg/kg
(Euthasol, Virbac Corp, Fort Worth, TX).
An arterial blood gas was analyzed at baseline, follow-
ing 2 hours of shock and the 6-hour observation period.
Resuscitation fluids
Normal saline (0.9% NaCl) was obtained from Hospira
inc. (Lake Forest, IL) and stored at room temperature.
FFP was isolated from healthy porcine donors. Briefly,
whole blood was captured in a blood collection bag and
centrifuged at 5000 g for 10 minutes at 4°C. The super-
natant was further centrifuged at 5000 g for 10 minutesto extract the plasma which was stored at −80°C. It was
thawed immediately prior to use.
Calculation of brain infarction and swelling
Brains were removed following euthanasia and were sliced
into 5 mm coronal sections. Slices were incubated in 2%
2,3,5-triphenyltetrazolium chloride (TTC) (SigmaChemical
Co., St. Louis, MO) to assess the presence of nonviable
tissue. Size of the lesion was measured with computer-
assisted image analysis software ImageJ (NIH, Bethesda,
MD). Brain swelling was calculated by comparing it to the
uninjured hemisphere [(ipsilateral hemisphere’s volume/
contralateral hemisphere’s volume) − 1] × 100 . True infarc-
tion volumes were corrected by the swelling factor.
Derived variables
Stroke volume (SV) was calculated as Cardiac Output/
Heart Rate. Systemic vascular resistance (SVR) was cal-
culated as 80 × (mean arterial pressure-central venous
pressure)/Cardiac Output.
Statistical analysis
Data are presented as mean ± standard error of the mean.
Brain lesion size and swelling as well as arterial blood gas
parameters were compared using an unpaired t-test.
For the purpose of comparing post-resuscitation hemo-
dynamic variables, following biostatistician consultation
we used a linear mixed model to compare value means
from end of resuscitation through the 6-hour observation
period between groups while correcting for intra-group
repeated measures. Based on these measurements, the
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timeframe in each group.
Sample size calculations were based on previously pub-
lished data [9,10] from the same model, and the group
sizes were sufficient to detect a 50% difference between
the groups for continuous variables (with variance of 25%
within the group), with a power (1-β) = 90% and α = 0.05.
All statistical analysis was done using SPSS 20.0 (IBM
Corp. Armonk NY).
Statistical significance was defined as p < 0.05.
Results
Arterial blood gas
Arterial blood gas values are listed in Table 1. At the
6-hour observation time point, fast infusion of FFP
was associated with higher hemoglobin levels com-
pared with stepwise FFP infusion (6.60 ± 0.44 g/dl vs.
5.12 ± 1.13 g/dl, p = 0.01) as well as higher lactate levels
(2.94 ± 0.22 mmol/l vs. 2.04 ± 0.12 mmol/l, p = 0.01). No
differences were found in the NS groups.
Systemic and pulmonary pressures
Hemodynamic variables are shown in Table 2 while
Figure 2 depicts selected variables from start of resusci-
tation and over the course of the 6-hour observation
period.Table 1 Arterial blood gas values
Group Baseline
pH FFP Fast 7.45 ± 0.02
FFP Slow 7.47 ± 0.02
NS Fast 7.44 ± 0.01
NS Slow 7.45 ± 0.01
pO2 (mmHg) FFP Fast 107.94 ± 6.37
FFP Slow 94.38 ± 2.08
NS Fast 105.52 ± 4.08
NS Slow 91.71 ± 2.41
pCO2 (mmHg) FFP Fast 36.94 ± 1.52
FFP Slow 35.98 ± 1.69
NS Fast 34.36 ± 2.29
NS Slow 38.52 ± 1.02
Hemoglobin (g/dl) FFP Fast 9.92 ± 0.43
FFP Slow 9.42 ± 0.24
NS Fast 9.12 ± 0.18
NS Slow 8.78 ± 0.25
Lactate (mmol/l) FFP Fast 1.60 ± 0.12
FFP Slow 1.50 ± 0.21
NS Fast 1.36 ± 0.16
NS Slow 1.44 ± 0.14
Data presented as mean ± standard error of the mean.
*Denotes comparisons between slow and fast infusion of similar fluid types at the 6In the FFP groups, fast resuscitation resulted in overall
higher mean arterial pressures (MAP, 55.90 ± 0.93 mmHg
vs. 53.39 ± 0.86 mmHg, p = 0.05) but similar central ven-
ous pressures (CVP). This was, however, associated with
a higher systemic vascular resistance in the fast resusci-
tation group (SVR, 1052.75 ± 65.90 mmHg vs. 761.63 ±
22.42 mmHg, p = 0.04) as well as a lower mean pulmonary
artery pressures (MPAP, 15.12 ± 1.26 mmHg vs. 23.11 ±
1.17 mmHg, p < 0.01).
In the NS groups, fast NS resuscitation resulted in an
overall higher MAP (52.93 ± 1.41 mmHg vs. 46.92 ± 1.30,
p = 0.01), but no difference in CVP. As in the FFP
groups, this was associated with a higher SVR (921.40 ±
19.42 mmHg vs. 573.41 ± 17.92 mmHg, p < 0.01).
Cardiac function
Cardiac function is summarized in Table 2 and Figure 3.
In both FFP and NS groups, fast resuscitation was asso-
ciated with overall lower cardiac outputs (FFP: 4.81 ±
1.50 l/min vs. 5.45 ± 1.14 l/min, p = 0.03; NS: 4.37 ±
0.12 l/min vs. 6.35 ± 0.10 l/min, p < 0.01). No differences
in stroke volume were observed.
Intracranial pressure and brain oxygenation
ICP and brain pO2 values are shown in Table 2 and
Figure 4. Fast resuscitation with FFP resulted higher ICPPost 2 hour shock 6 hour observation p-value*
7.37 ± 0.03 7.50 ± 0.02 0.84
7.45 ± 0.01 7.49 ± 0.01
7.41 ± 0.02 7.43 ± 0.02 0.21
7.43 ± 0.01 7.39 ± 0.03
97.26 ± 2.91 99.72 ± 7.55 0.99
103.54 ± 8.68 99.72 ± 1.95
99.50 ± 5.11 92.98 ± 5.02 0.10
97.67 ± 3.24 81.45 ± 3.70
42.16 ± 1.50 38.26 ± 1.44 0.61
31.92 ± 1.55 39.25 ± 1.18
41.36 ± 3.95 37.24 ± 1.93 0.93
35.94 ± 1.74 37.49 ± 1.92
10.74 ± 0.28 6.60 ± 0.44 0.01
10.32 ± 0.14 5.12 ± 1.13
10.06 ± 0.47 6.58 ± 0.29 0.10
10.02 ± 0.21 5.98 ± 0.23
5.18 ± 1.18 2.94 ± 0.26 0.01
3.64 ± 0.07 2.04 ± 0.12
3.20 ± 0.50 1.48 ± 0.29 0.74
4.46 ± 1.44 1.34 ± 0.30
-hour observation time point. P-values in bold indicate significant differences.
Table 2 Hemodynamic variables, intracranial pressure and brain oxygenation
Group Baseline Post 2 hour shock Post resuscitation and 6 hour observation* p-value#
Heart rate (Beats/min) FFP Fast 110.83 ± 9.83 182.67 ± 6.66 144.94 ± 7.45 0.27
FFP Slow 112.20 ± 3.12 215.80 ± 8.84 156.83 ± 7.13
NS Fast 108.00 ± 10.33 177.00 ± 17.60 123.51 ± 6.70 0.01
NS Slow 97.00 ± 4.11 204.67 ± 8.18 149.00 ± 6.16
MAP (mmHg) FFP Fast 73.83 ± 3.59 31.66 ± 0.0.99 55.90 ± 0.93 0.05
FFP Slow 64.40 ± 2.69 34.20 ± 3.01 53.39 ± 0.86
NS Fast 77.50 ± 6.82 32.25 ± 0.95 52.93 ± 1.41 0.01
NS Slow 59.17 ± 3.64 30.00 ± 0.52 46.92 ± 1.30
spO2 (%) FFP Fast 94.86 ± 0.40 92.00 ± 1.57 94.22 ± 0.52 0.06
FFP Slow 94.00 ± 0.89 90.00 ± 2.63 92.79 ± 0.49
NS Fast 94.25 ± 0.48 92.50 ± 3.88 94.05 ± 0.34 <0.01
NS Slow 94.00 ± 0.52 94.17 ± 1.19 91.37 ± 0.43
MPAP (mmHg) FFP Fast 19.33 ± 1.69 12.17 ± 3.16 15.12 ± 1.26 <0.01
FFP Slow 16.00 ± 1.70 20.60 ± 4.82 23.11 ± 1.17
NS Fast 20.75 ± 1.32 14.50 ± 6.00 18.93 ± 0.85 0.66
NS Slow 17.33 ± 1.82 14.67 ± 1.99 20.22 ± 1.16
CVP (mmHg) FFP Fast 2.50 ± 1.50 −3.83 ± 1.85 −0.07 ± 0.92 0.03
FFP Slow 2.40 ± 1.81 −0.60 ± 2.34 2.85 ± 0.85
NS Fast 5.00 ± 0.71 0.01 ± 1.78 3.50 ± 1.08 0.90
NS Slow 3.50 ± 1.25 −7.50 ± 8.56 3.31 ± 0.99
Cardiac Output (l/min) FFP Fast 5.17 ± 0.51 1.85 ± 1.13 4.81 ± 1.50 0.03
FFP Slow 5.90 ± 0.27 2.38 ± 0.46 5.45 ± 1.14
NS Fast 5.65 ± 0.49 1.75 ± 0.15 4.37 ± 0.12 <0.01
NS Slow 5.77 ± 0.55 2.05 ± 0.37 6.35 ± 0.10
ICP (mmHg) FFP Fast 7.33 ± 0.71 5.29 ± 0.97 9.10 ± 0.72 0.02
FFP Slow 3.40 ± 1.36 1.80 ± 1.74 6.36 ± 0.68
NS Fast 5.75 ± 0.48 5.87 ± 1.63 9.39 ± 0.83 0.11
NS Slow 4.00 ± 1.13 −0.33 ± 1.08 7.50 ± 0.76
Brain pO2 (mmHg) FFP Fast 14.80 ± 2.63 7.37 ± 1.48 10.42 ± 2.33 0.87
FFP Slow 13.76 ± 2.68 6.20 ± 1.29 9.90 ± 2.28
NS Fast 12.00 ± 1.14 5.87 ± 1.63 10.32 ± 1.90 0.09
NS Slow 13.87 ± 3.65 8.90 ± 3.96 14.54 ± 1.56
Stroke volume (ml/stroke) FFP Fast 47.51 ± 3.90 10.41 ± 0.94 33.26 ± 1.64 0.25
FFP Slow 52.55 ± 1.50 11.48 ± 2.88 35.90 ± 1.54
NS Fast 53.15 ± 5.12 10.10 ± 0.96 42.93 ± 4.63 0.87
NS Slow 58.86 ± 3.25 10.18 ± 2.09 41.92 ± 4.28
SVR (dyn*s/cm5) FFP Fast 1137.63 ± 3.34 1566.77 ± 163.67 1052.75 ± 65.90 0.04
FFP Slow 850.13 ± 61.00 1280.60 ± 149.39 761.63 ± 22.42
NS Fast 1059.18 ± 163.17 1482.81 ± 51.77 921.40 ± 19.42 <0.01
NS Slow 822.37 ± 107.35 1468.74 ± 132.93 573.41 ± 17.92
SPB: Systolic blood pressure; MAP: Mean arterial pressure; MPAP: Mean pulmonary artery pressure; CVP: Central venous pressure; ICP: Intracranial pressure; SVR:
Systemic vascular resistance. (*) Estimated marginal means by the statistical model throughout the 6-hour observation phase. (#) Comparisons of same fluid type
estimated means using a linear mixed model. P-values in bold indicate significant differences.
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Figure 2 Mean arterial pressure (top), heart rate (middle) and systemic vascular resistance (bottom) over the course of the 6-hour post
resuscitation period. Data presented as means ± standard error of the mean.
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no difference in brain oxygenation compared with step-
wise resuscitation. No differences were observed in the
NS groups.Lesion size and brain swelling
Lesion sizes and brain swelling is shown in Figure 4. Fast
resuscitation with FFP resulted in increased brain swelling
(22.36 ± 1.03% vs. 15.58 ± 2.52%, p = 0.04) but similar lesion
sizes (2160.24 ± 202.56 mm3 vs. 2141.32 ± 256.27 mm3,
p = 0.96) compared with stepwise FFP resuscitation. Fast
resuscitation with normal saline resulted in increased
brain swelling (37.24 ± 1.63% vs. 26.74 ± 1.33%, p = 0.05)
as well as lesion size (3285.44 ± 130.81 mm3 vs. 2509.41 ±
297.44 mm3, p = 0.04).Discussion
In this study we found that bolus resuscitation with both
FFP and NS resulted in adverse outcome compared with
stepwise resuscitation. In the NS group, bolus resuscitation
was associated with a significant increase in both brain
swelling and lesion size, despite the fact that peripheral
oxygenation (spO2) was higher in the bolus resuscitation
group. Furthermore, a significant decrease in cardiac output
coupled with an increase in systemic vascular resistance
suggests that increased fluid extravasation may have
compromised the resuscitative outcome.
In the FFP groups, these changes were mirrored although
less pronounced. Bolus resuscitation was associated with
increased fluid extravasation in the brain as well higher
systemic vascular resistance, higher hemoglobin levels
(suggesting less hemodilution and thus increased fluid
Figure 3 Cardiac output (top), stroke volume (middle) and mean pulmonary artery pressure (bottom) over the course of the 6-hour
post resuscitation period. Data presented as means ± standard error of the mean.
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did, however, not appear to impact greatly on brain
lesion size.
Overall, these findings are in line with previous reports
suggesting that bolus resuscitation following hemorrhagic
shock may be associated with adverse outcome [4-6].
Indeed, bolus infusion of crystalloids have been shown
to increase bleeding and shorten survival times in a
rodent model of hemorrhage following splenic injury
compared to slow infusion [4]. Furthermore, while brisk
infusion of normal saline may results in fluid extravasation
in excess of 100 ml/min in humans, doubling the infusion
time while maintaining equal fluid volume may result
in a four time reduction of fluid extravasation rates, thus
improving the volume load over time [11]. These results
furthermore support the growing body of evidence sug-
gesting favorable outcome when low volume resuscitationis used [12-14], but does raise the question of whether the
beneficial effects are due to low volume or low infusion/
perfusion pressures, or a combination.
Although this study was not designed for investigating
the underlying pathophysiological mechanisms, some po-
tential explanations may be considered. Following the
classic line of thinking proposed by Starling [15], the
greater increase in hydrostatic pressure during bolus
resuscitation may drive a net fluid shift out of the vas-
cular bed as oncotic pressures remain equal due to the
equal amounts of identical fluids used. This is supported
by findings indicating less early fluid extravasation in anes-
thetized compared to non-anesthetized patients receiving
equal crystalloid volume loads [16-18], presumably due
to vascular relaxation and concomitant lower perfusion
pressures rather than choice of anesthetic agent [19]. In
contrast, the degree of fluid extravasation following FFP
Figure 4 Intracranial pressure (top) and brain oxygenation (middle) over the course of the 6-hour post resuscitation period. Bottom bar
graphs depict brain swelling (left) and lesion size (right) following the 6-hour observation period. Data presented as means ± standard error of the mean.
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experiments using artificial colloids suggest that fluids ex-
travasation may actually be increased during anesthesia
[20]. The increased colloid osmotic pressure of FFP com-
pared with NS may, however, counteract extravasation in
the FFP groups with a resulting smaller difference in the
hemodynamic response between bolus and slow resuscita-
tion groups. Indeed, a differential effect on colloid osmotic
pressure between crystalloids and artificial colloids has
been demonstrated [21].
Recent evidence have challenged the classic Starling
approach indicating a pivotal role of the semi-permeable
layer formed by the endothelial glycocalyx [22]. This bar-
rier coats the vascular endothelium and is comprised of
membrane bound proteoglycans, glycoproteins and plasma
proteins comprising a non-circulating intravascular layer of
an estimated 700–1.500 ml [23,24]. The integrity of the
subglycolayx layer as well as the starling forces operatingherein, more than intra and extravascular colloid osmotic
and hydrostatic pressures seem determine net fluid shifts
[25,26]. It therefore follows that an intact and functional
endothelial glycocalyx is pivotal for optimal resuscitative
outcome.
Interestingly, volume loading with a concomitant in-
creased stretch of the atrial walls release atrial natriuretic
peptide (ANP), which directly induce shedding of the
endothelial glycocalyx [27,28]. Rapid reconstitution of
the vascular volume may thus induce increased atrial
stretching and ANP release, directly inducing glycococalyx
shedding and increased fluid extravasation. Of note, recent
evidence suggests that FFP may protect or even reconsti-
tute the endothelial glycocalyx [29,30], which may account
for the less pronounced fluid extravasation observed in the
FFP groups in this study.
Several limitations exist in this study and deserve to be
acknowledged. We have chosen a 6-hour post-resuscitation
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on the long-term consequences of different resuscitation
strategies. Indeed, the minor changes observed in ICP
suggests that the observed brain swelling is likely not of
clinical significance at this time point. The differential
ICP and brain oxygenation trajectories evident from
Figure 4 does, however, suggest that differences would only
be exaggerated if the observation phase was extended.
The 6-hour observation time point does not allow us
to conclude on the effects on clinically relevant outcome
parameters such as neurofunctional status. The focus on
brain lesion size, an end-point parameter of clear clinical
relevance, still allows us to conclude on the clinical
relevance of the differences observed in this model. A
long-term survival model has been developed to address
these important questions.
In line with this, the presented data does not allow us
to conclude on the mechanistics underlying the observed
differences. These issues are, however, the object of future
more focused studies.
Secondly, neither NS nor FFP are usually employed as
stand-alone resuscitative agents in the treatment of HS,
bringing the clinical translatability of the model into
question. Indeed, the use of packed red blood cells
(PRBC’s) and platelets is standard of care in resuscitation
of HS. We opted not to include PRBC’s and platelets in
the resuscitation protocols since we wanted to examine
the isolated effects of different resuscitation fluids rather
than introduce the potential confounding effects of
multiple fluids with unknown interactions. Indeed, the
isolated effect of PRBC or platelet infusion speed on
hemodynamics is unknown.
Third, the choice of bolus infusion speeds may be debat-
able. Indeed, we used maximum NS infusion speeds of
165/ml and FFP infusion speeds of 50 ml/min, which may
appear higher than what is commonly used. It is, however,
important to note that gravity alone can produce infusion
crystalloid rates of 123 ml/min [31], pressure bags 257 ml/
min [31] while rapid infusers such as the Level 1 (Level 1
technologies, Rockland, MA) and Rapid infusion system
(Heamonetics Corp, Braintree, MA) can deliver infusion
rates in excess of 800 ml/min [32].
In conclusion, in this study we found that bolus resus-
citation with both NS and FFP following TBI and shock
was associated with increased brain swelling in both
groups as well as increased lesion size in the NS groups
when compared to stepwise resuscitation. If these find-
ings translate to humans it is concerning that widely
used protocols such as the ATLS [3] still call for rapid
infusion of crystalloids as the initial resuscitative adjunct
in hypotensive patients.Competing interests
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